Modulating astrogliosis after neurotrauma

Journal of Neuroscience Research

Volumn 63, Issue 2, 2001, Pages 109-115

  McGraw, J ^a   Hiebert, G W ^a   Steeves, J D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CNS; ECM; Glial scar formation; Regeneration; Spinal cord or brain injury

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; ASTROCYTOSIS; BRAIN INJURY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENETIC MANIPULATION; GLIA CELL; MOUSE; NERVE FIBER REGENERATION; NERVE REGENERATION; NERVOUS SYSTEM INJURY; NONHUMAN; PRIORITY JOURNAL; SCAR; SHORT SURVEY; SPINAL CORD INJURY; TECHNIQUE; TRANSGENE;

ANIMALS; ASTROCYTES; BRAIN INJURIES; GLIOSIS; HUMANS; NERVE REGENERATION;

EID: 0035863456     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J     Document Type: Short Survey

References (66)

1. Attenuation of astroglial reactivity by interleukin-10
2. Neurite outgrowth inhibitor of gliotic brain tissue. Mode of action and cellular localization, studied with specific monoclonal antibodies
3. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
4. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice
5. Ultrastructural study on meningeal regeneration and meningo-glial relationships after cerebral stab wound in the adult rat
6. Regeneration of cut adult axons fails even in the presence of continuous aligned glial pathways
7. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord
8. Conditional ablation of cerebellar astrocytes in postnatal transgenic mice
9. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord
10. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease
11. Glial fibrillary acidic protein (GFAP): The major protein of glial intermediate filaments in differentiated astrocytes
12. The tenascin gene family in axon growth and guidance
13. The glial scar and central nervous system repair
14. Involvement of a chondroitin sulfate proteoglycan in the avoidance of chick epidermis by dorsal root ganglia fibers: A study using beta-D-xyloside
15. Glial cell extracellular matrix: Boundaries for axon growth in development and regeneration
16. Inflammation and the glial scar: Factors at the site of injury that influence regeneration in the central nervous system
17. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury
18. Advanced transgenic and gene-targeting approaches
19. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
20. Functions of brain chondroitin sulfate proteoglycans during developments: Interactions with adhesion molecules
21. Ineffectiveness of enzyme therapy on regeneration in the transected spinal
22. Astroglia in CNS injury
23. Matrix proteoglycans: From molecular design to cellular function
24. Transcriptional and posttranscriptional regulation of proteoglycan gene expression
25. Effect of transforming growth factor beta 1 on spinal motor neurons after axotomy
26. Identification of a neural stem cell in the adult mammalian central nervous system
27. Severed corticospinal axons recover electrophysiologic control of muscle activity after x-ray therapy in lesioned adult spinal cord
28. Structural recovery in lesioned adult mammalian spinal cord by x-irradiation of the lesion site
29. Selective ablation of astrocytes by intracerebral injections of alpha-aminoadipate
30. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
31. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation
32. Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse
33. Conditional genome alteration in mice
34. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat
35. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2
36. Nervous tissue proteoglycans
37. Transforming growth factor beta 1 is a potent survival factor for rat embryo motoneurons in culture
38. Abstract from the Asia Pacific symposium on neural regeneration. The glial toxin L-alphaaminoadipic acid selectively removes reactive astrocytes after spinal cord lesion
39. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars
40. Molecular recognition in procollagen chain assembly
41. Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury
42. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation
43. Robust regeneration of CNS axons through a track depleted of CNS glia
44. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor
45. Astrocyte responses to CNS injury
46. Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development
47. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally
48. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin
49. Reactive astrocytes: Cellular and molecular cues to biological function
50. Effects of spinal cord X-irradiation on the recovery of paraplegic rats
51. Putative gliotoxin, alpha-aminoadipic acid, fails to kill hippocampal astrocytes in vivo
52. Mice develop normally without tenascin
53. Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors
54. Engines, accelerators, and brakes on functional spinal cord repair
55. Tenascin knockout mice: Barrels, boundary molecules, and glial scars
56. Inhibition of collagen IV deposition promotes regeneration of injured CNS axons
57. Fine structural changes in the rat brain after local injections of gliotoxin, alpha-aminoadipic acid
58. Targeted gene disruption: Applications in neurobiology
59. Axonal and nonneuronal cell responses to spinal cord injury in mice lacking glial fibrillary acidic protein
60. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene
61. Elimination of basal lamina and the collagen "scar" after spinal cord injury fails to augment corticospinal tract regeneration
62. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection
63. Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury
64. Matrix metalloproteinases and diseases of the CNS
65. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan
66. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue